Found: 13
Select item for more details and to access through your institution.
Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261982
- By:
- Publication type:
- Article
Combination of carriers, with complementary intratumoral microdistributions of delivered αparticles, may realize the promise for Actinium-225 in large solid tumors.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262992
- By:
- Publication type:
- Article
Preclinical evaluation of <sup>213</sup>Bi-/<sup>225</sup>Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.256388
- By:
- Publication type:
- Article
Preclinical evaluation of <sup>203/212</sup>Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229393
- By:
- Publication type:
- Article
Comparative Dosimetry for <sup>68</sup>Ga-DOTATATE: Impact of Using Updated ICRP Phantoms, S Values, and Tissue-Weighting Factors.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 8, p. 1281, doi. 10.2967/jnumed.117.203893
- By:
- Publication type:
- Article
Imaging of Programmed Cell Death Ligand 1: Impact of Protein Concentration on Distribution of Anti-PD-L1 SPECT Agents in an Immunocompetent Murine Model of Melanoma.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 10, p. 1560, doi. 10.2967/jnumed.117.193268
- By:
- Publication type:
- Article
(2S)-2-(3-(1-Carboxy-5-(4-<sup>211</sup>At-Astatobenzamido)Pentyl) Ureido)-Pentanedioic Acid for PSMA-Targeted a-Particle Radiopharmaceutical Therapy.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 10, p. 1569, doi. 10.2967/jnumed.116.174300
- By:
- Publication type:
- Article
Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [<sup>225</sup>Ac]Ac-DOTA-TDA-Lipiodol<sup>®</sup> against hepatic tumors.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00205-3
- By:
- Publication type:
- Article
Two diverse carriers are better than one: A case study in α‐particle therapy for prostate specific membrane antigen‐expressing prostate cancers.
- Published in:
- Bioengineering & Translational Medicine, 2022, v. 7, n. 2, p. 1, doi. 10.1002/btm2.10266
- By:
- Publication type:
- Article
Anti-GD2 antibody for radiopharmaceutical imaging of osteosarcoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4382, doi. 10.1007/s00259-022-05888-5
- By:
- Publication type:
- Article
Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 13, p. 4246, doi. 10.1007/s00259-021-05406-z
- By:
- Publication type:
- Article
Accuracy in dosimetry of diagnostic agents: impact of the number of source tissues used in whole organ S value-based calculations.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-0614-6
- By:
- Publication type:
- Article
Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model.
- Published in:
- EJNMMI Research, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13550-017-0303-2
- By:
- Publication type:
- Article